Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 792

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 792
---
 available under the 2017 Plan as of December 31, 2023, is 440 shares, less the number of shares of common stock issued under the Del Mar (BC) 2013 Amended and Restated Stock Option Plan (the “Legacy Plan”), or that are subject to grants of stock options made, or that may be made, under the Legacy Plan, or that have been previously exercised. The following table sets forth the aggregate information on all equity compensation plans as of December 31, 2023:

| Plan (in thousands, except per                                                             
 share amounts)                                                                             |     | Number of shares of       
 common stock to be        
 issued upon exercise of   
 outstanding stock options 
 and                       
 rights                    
 (a)                       |     |     | Weighted-average  
 exercise price of 
 stock options and 
 rights            
 $                 |          |     | Number of shares of common stock   
 remaining available for future     
 issuance under equity compensation 
 plans                              
 (excluding securities reflected    
 in column (a))(2)                  |     |
| Equity compensation plans approved by security holders - 2017 Plan(1)                      |     |                           | 236 |     |                   |    21.16 |     |                                    | 129 |
| Equity compensation plans not approved by security holders - Del Mar (BC) 2013 Amended and 
 Restated Stock Option Plan                                                                 |     |                           |   1 |     |                   | 2,175.08 |     |                                    |   — |
| Totals                                                                                     |     |                           | 237 |     |                   |    32.92 |     |                                    | 129 |

| (1) | The Del Mar (BC) 2013 Amended and Restated Stock Option Plan refers to the Company’s previous equity 
 compensation plan.                                                                                   |

| (2) | The balance of 91 shares of common stock available for issuance under the 2017 Plan as of December 31, 
 2023, is net of stock options previously exercised.                                                    |

F-60

Kintara Therapeutics, Inc. Notes to Condensed Consolidated Interim Financial Statements (Unaudited) December 31, 2023 (expressed in US dollars and in thousands, except par value and per share amounts, unless otherwise noted) The maximum number of shares of Company common stock with respect to which any one participant may be granted awards during any calendar year is 8% of the Company’s fully diluted shares of common